Clinical trials
Completed Cellulitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
115 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 6 |
| 2007 | 10 |
| 2008 | 15 |
| 2009 | 4 |
| 2010 | 8 |
| 2011 | 5 |
| 2012 | 12 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 7 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 115 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 9 |
| 59th Medical Wing | 3 |
| Brigham and Women's Hospital | 3 |
| Durata Therapeutics Inc., an affiliate of Allergan plc | 3 |
| Forest Laboratories | 3 |
| Melinta Therapeutics, Inc. | 3 |
| Ohio State University | 3 |
| Pfizer | 3 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 3 |
| Arpida AG | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cellulitis | 115 |
| Abscess | 28 |
| Wound Infection | 13 |
| Bacterial Infections | 12 |
| Infections | 10 |
| Soft Tissue Infections | 10 |
| Skin Diseases | 9 |
| Pneumonia | 8 |
| Staphylococcal Infections | 8 |
| Skin Diseases, Bacterial | 7 |
Trials
Showing 1 to 25 of 115. Each trial links to its page on Pharma Observatory.
15 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.